Selskabets formål er at drive Farmakonomskolen, et konferencecenter samt et uddannelses- og udviklingscenter for farmaceutisk praksis, herunder: - at drive uddannelses- og konsulentvirksomhed til ledere og medarbejdere på apotekerne i Danmark - at udvikle informations- og uddannelsesmateriale til apotekssektoren - at uddanne farmakonomer, herunder udvikle undervisningsmaterialer - at drive forskning og udvikling indenfor lægemiddelanvendelse og sikker medicinering - at levere uddannelse og konsulentbistand til den farmaceutiske industri, sygehusapoteker og deres leverandører - at drive et konferencecenter med lokaler, værelser og faciliteter.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 141.3 mio. | 1.9 mio. | 126.4 mio. | 101.9 mio. | 139 | |
CVR: 10038839
Secondary names: APOTEKERNES KONFERENCE- OG UDDANNELSESCENTER A/S, DANISH COLLEGE OF PHARMACY PRACTICE A/S, FARMAKONOMSKOLEN A/S
Previous names: DANMARKS APOTEKERFORENINGS KURSUSEJENDOM A/S
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 752 companies in Drift af hoteller og lignende overnatningsfaciliteter
Comparison is based on industry median values
Line Holst Bruun joined the board
Morten Topp joined the board
Susanne Christina Langager joined the board
Ditte Poulsen joined the board
Kirsten Holme Christensen left the board
Line Holst Bruun left the board
Lars Pram Olsen joined the board
Tue Askaa left the board
Rikke Spangenberg left the board
Companies in the same industry and area
CVR 10282977
CVR 31441668
CVR 25938739
CVR 65954753
CVR 41206691
PHARMAKON A/S demonstrates a stable financial health with consistent revenue growth, reaching 141.35 million DKK in 2024, up from 140.53 million DKK in 2023. However, profit has seen a decline, dropping from 5.1 million DKK in 2023 to 1.89 million DKK in 2024, indicating potential challenges in maintaining profitability despite revenue increases. The company's equity position is strong at 101.86 million DKK, reflecting a solid foundation in the hospitality sector. While revenue trends are positive, the declining profit margins raise concerns about operational efficiency and cost management. Overall, PHARMAKON A/S holds a stable position within the hotel and accommodation industry, but must address profitability challenges to sustain growth.
AI-generated summary
companydata.dk